Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

353 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
Krakauer M, Sorensen PS, Sellebjerg F. Krakauer M, et al. Among authors: sorensen ps. J Neuroimmunol. 2006 Dec;181(1-2):157-64. doi: 10.1016/j.jneuroim.2006.09.006. Epub 2006 Nov 1. J Neuroimmunol. 2006. PMID: 17081623 Clinical Trial.
Lymphocyte glutathione peroxidase activity during exacerbations in multiple sclerosis.
Sørensen PS, Hansen JC, Mai J, Nielsen LR, Sørensen T. Sørensen PS, et al. Among authors: sorensen t. Biol Trace Elem Res. 1992 Apr-Jun;33:145-50. doi: 10.1007/BF02784003. Biol Trace Elem Res. 1992. PMID: 1379452
The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis.
Ravnborg M, Liguori R, Christiansen P, Larsson H, Sørensen PS. Ravnborg M, et al. Among authors: sorensen ps. Neurology. 1992 Jul;42(7):1296-301. doi: 10.1212/wnl.42.7.1296. Neurology. 1992. PMID: 1620337
High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium.
Mai J, Sørensen PS, Hansen JC. Mai J, et al. Among authors: sorensen ps. Biol Trace Elem Res. 1990 Feb;24(2):109-17. doi: 10.1007/BF02917200. Biol Trace Elem Res. 1990. PMID: 1702664
Treatment of multiple sclerosis with IVIg: potential effects and methodology of clinical trials.
Sørensen PS. Sørensen PS. J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):62-4. doi: 10.1136/jnnp.57.suppl.62. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964858 Free PMC article. Review.
Cerebral metabolism in a case of multiple sclerosis with acute mental disorder.
Blinkenberg M, Rune K, Jønsson A, Holm S, Jensen CV, Paulson OB, Sørensen PS. Blinkenberg M, et al. Among authors: sorensen ps. Acta Neurol Scand. 1996 Nov;94(5):310-3. doi: 10.1111/j.1600-0404.1996.tb07071.x. Acta Neurol Scand. 1996. PMID: 8947281
Intravenous immunoglobulin G therapy: effects of acute and chronic treatment in multiple sclerosis.
Sørensen PS. Sørensen PS. Mult Scler. 1996 Jul;1(6):349-52. doi: 10.1177/135245859600100614. Mult Scler. 1996. PMID: 9345416 Review.
Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis.
Sorensen PS, Wanscher B, Jensen CV, Schreiber K, Blinkenberg M, Ravnborg M, Kirsmeier H, Larsen VA, Lee ML. Sorensen PS, et al. Neurology. 1998 May;50(5):1273-81. doi: 10.1212/wnl.50.5.1273. Neurology. 1998. PMID: 9595974 Clinical Trial.
Biological markers in body fluids for activity and progression in multiple sclerosis.
Sørensen PS. Sørensen PS. Mult Scler. 1999 Aug;5(4):287-90. doi: 10.1177/135245859900500416. Mult Scler. 1999. PMID: 10467390 Review.
The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group.
Koch-Henriksen N, Sørensen PS. Koch-Henriksen N, et al. Among authors: sorensen ps. Mult Scler. 2000 Jun;6(3):172-5. doi: 10.1177/135245850000600306. Mult Scler. 2000. PMID: 10871828 Clinical Trial.
353 results
Jump to page